Dr Adam Hartley

Sub-speciality: Interventional Cardiology.

02036532005

Overview

Dr Adam Hartley MBBS PhD BSc(Hons) MRCP(UK) DIC PGCert is a Consultant Cardiologist at OneWelbeck. He also specialises in coronary and structural intervention at Imperial College Healthcare NHS Trust and an Honorary Clinical Lecturer in cardiovascular sciences at the National Heart and Lung Institute (NHLI), Imperial College London.

About Dr Adam Hartley

Dr Adam Hartley MBBS PhD BSc (Hons) MRCP (UK) DIC PGCert is a Consultant Cardiologist specialising in Coronary and Structural Intervention at Imperial College Healthcare NHS Trust and an Honorary Clinical Lecturer in Cardiovascular Sciences at the National Heart and Lung Institute (NHLI), Imperial College London. He is currently the Clinical Governance Lead for the Cardiology Department.

He completed his undergraduate training at Guy's, King's and St Thomas' Medical School in 2013, achieving all distinctions. This included an intercalated BSc in pharmacology for which he was awarded 1st class honours and the 'Best Intercalating Student in Pharmacology Award'. He was also awarded a scholarship from the British Heart Foundation.

He undertook his general medical training from 2013 to 2016 in North West London, which included training in cardiology, heart and lung transplantation, as well as respiratory medicine.

Dr Hartley was awarded a merit for completing a post graduate certificate in medical education from Cardiff University in 2016.

He was appointed as a National Institute for Health Research academic clinical fellow in cardiology at Imperial College London and specialist registrar at Imperial College Healthcare NHS Trust 2017-2019, during which time he completed his general cardiology training.

Dr Hartley has completed a PhD in cardiovascular sciences in the National Heart and Lung Institute, Imperial College London, which focused on the prediction, detection and treatment of atherosclerotic plaques that are at high risk of future rupture and the culprit for heart attacks. His research was supported by a prestigious Wellcome Trust PhD Fellowship. Amongst other accolades, he was awarded a Basic Science Registration Grant from the European Society of Cardiology, as well as being a finalist for the British Cardiovascular Intervention Society Young Investigator Award and Royal Society of Medicine Cardiology President’s Prize.

Areas of Expertise

Dr Adam Hartley commonly treats:

Chest pain
Angina
Heart attacks
Palpitations
Heart failure
Hypertension
Heart Valve Disease
Arrhythmias
Valvular Heart Disease including Aortic Stenosis and Aortic Regurgitation
High Cholesterol
Myocarditis
Pericarditis

He performs a range of tests and treatments including:

Coronary angiography
Coronary angioplasty (PCI)
Transcatheter Aortic Valve Implantation (TAVI)
Intravascular Ultrasound
Invasive Pressure Wire assessments
Optical Coherence Tomography
Echocardiography
24-hour tape monitoring
24-hour blood pressure monitoring
Cardioversion (DCCV)
Exercise Tolerance Testing
Cardiovascular risk assessment

Additional Information

Dr Adam Hartley's active memberships:

Royal College of Physicians
British Cardiovascular Society
European Society of Cardiology
British Cardiovascular Intervention Society
British Society of Echocardiography

Dr Adam Hartley currently holds clinical posts at:

OneWelbeck Heart Health
Imperial College Healthcare NHS Trust (Hammersmith and St Mary's Hospitals)
Imperial College Private Healthcare

His professional awards include:

ACS Infectious Diseases Early Career Prize (2025)
British Thoracic Society Mid-Career Investigator Prize (2024)
Top peer reviewer Award, American J Respiratory and Critical Care Med (2022)
Top Peer Reviewer Award, European Respiratory Journal (2020)
Apothecaries prize for best research paper on therapeutics theme (2019)
Rising Star award, International Workshop for Lung Health, Monaco (2016)
British Thoracic Society Early Career Investigator Prize (2015)
COPD research award – European Respiratory Society (2012).

Research Highlights

Dr Hartley's research interests include coronary artery disease, vulnerable atherosclerotic prone to rupture as well as structural heart interventions

His research highlights include:

Hartley A., Marshall DC., Salciccioli JD., Sikkel MB., Maruthappu M., Shalhoub J. Trends in Mortality from Ischaemic Heart Disease and Cerebrovascular Disease in Europe: 1980-2009. 2016. Circulation. PMID: 27006480. https://pubmed.ncbi.nlm.nih.gov/27006480/

Hartley A., Haskard D., Khamis R. Oxidized LDL and anti-oxidized LDL antibodies in atherosclerosis - Novel insights and future directions in diagnosis and therapy. 2019. Trends Cardiovasc Med. PMID: 29934015. https://pubmed.ncbi.nlm.nih.gov/29934015/

Alshahrani N., Hartley A. et al. Remote Acute Assessment of Cardiac Patients Post-Acute Coronary Syndrome (TELE-ACS): A Randomized Controlled Trial. 2024. JACC. PMID: 38588928. https://pubmed.ncbi.nlm.nih.gov/38588928/

Hartley A. et al. Trends in Mortality from Aortic Stenosis in Europe: 2000–2017. 2021. Front Cardiovasc Med. PMID: 34708094. https://pubmed.ncbi.nlm.nih.gov/34708094/

Alexiadou K., Hartley A., et al. The cardiovascular effects of GLP-1 receptor agonists beyond obesity and type 2 diabetes: An anti-atherosclerotic action. 2024. Trends Cardiovasc Med. PMID: 38555029. https://pubmed.ncbi.nlm.nih.gov/38555029/

Reviews

Major insurers served

If your insurer is not listed, please contact us to confirm your coverage. Please note this does not guarantee coverage or fee assurance. Patients should confirm with their insurer to ensure coverage, check if the doctor is fee-assured, or verify if their policy includes the doctor in question.